Indian Pharma Legal & Regulatory Intelligence
A unified India-focused intelligence system covering pharmaceutical laws, rules, regulatory developments, judgments, compliance, enforcement and legal alerts.
Six Core Intelligence Sections
Independent modules • Individually editableIndian Pharma Laws
Acts and primary pharmaceutical legislation governing the Indian pharmaceutical sector.
Rules & Regulations
Indian pharmaceutical rules, schedules, requirements and regulatory provisions.
Regulatory Notifications
Indian regulatory notifications, amendments, circulars and important regulatory changes.
Court Judgments & Legal Opinions
Indian pharmaceutical-related judgments, legal opinions, interpretations and important precedents.
Compliance & Enforcement
Pharmaceutical compliance requirements, inspections, violations, enforcement actions and recalls.
Legal / Regulatory Alerts
Important Indian pharmaceutical legal and regulatory developments requiring attention.
The six sections are independent modules. Their content can be created, edited, replaced, updated or removed separately. This master dashboard contains no WordPress page links and does not require modification when an individual section is updated.
Pharma Legal, Enforcement & Alert Intelligence
Source-linked judgments, compliance and enforcement developments, and regulatory alerts.
Alert monitor last checked: 2026-09-05 18:25:31
Court Judgments & Legal Opinions
Pharma-related cases, judgments, legal opinions and precedents.
148 recordsOpen Section →02
Compliance & Enforcement
Compliance requirements, inspections, violations, enforcement actions and recalls.
27 recordsOpen Section →03
Legal / Regulatory Alerts
Important legal and regulatory developments requiring attention.
503 recordsOpen Section →
Legal / Regulatory Alerts · 503 visible records
NDCTR_G.S.R. 835(E) dt_22.11.2022_Amendment in First Schedule for non clinical testing methods for new drugs (Pluripotent)
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →2022.11.17_Final GSR 823(E)_Amendment in rule 96 for mandating Bar or QR code on the label of top 300 brand in Drugs Rules
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →2022.11.02_S.O. 5090(E)_Notification of eligible officers at CDTL Chennai as Govt Analyst under section 20 of the Drugs and Cosmetics Act 1940
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →MDR_G.S.R. 777(E) dt_14.10.2022_exemption of non sterile and non measuring Class A medical devices from licensing regime
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →2022.09.28_S.O. 4574(E)_Designation of Government Analysts at RDTL Chandigarh as MDTO as per MDR 2017
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →2022.09.20_Draft_GSR 710(E)_Exemption of certain Class A medical device from licensing regime
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →2022.08.10_Final GSR 623(E)_To include colour of disinfectants in rule 127 of Drugs Rules 1945.
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →Extract of the New Drugs and Clinical Trials Rules 2019 relevant to Ethics Committee for Clinical Trial, Bioavailability and Bioequivalence study
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →2022.08.02_S.O. 3739(E)_Notification of Medical Devices Testing Officer for CMDTL
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →2022.06.30_Final GSR 502(E)_Proviso to Sr.no 39 in Sch K for Liquid Antiseptics in Drugs Rules
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →2022.06.15_Final GSR 450(E)_To amend Fourth Schedule wrt TSE or BSE certificate under MDR
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →22.06.14_Draft_GSR 448(E)_Amendment in rule 96 for mandating Bar code or QR code on the label of top 300 brand in Drugs Rules
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →2022.05.25_Draft_GSR 393(E)_Exemption under Schedule K of the Drugs Rules, 1945 for OTC drugs
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →2022.05.23_Draft GSR 383(E)_Proviso to Sr.no 39 in Sch K for Liquid Antiseptics in Drugs Rules
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →2022.05.18_Final GSR 356(E)_Insert rule 43A for Suspension and cancellation of license in MDR 2017
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →2022.05.18_Final GSR 357(E)_Inclusion of Acitretin in Sch H of Drugs Rules 1945
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →2022.03.29_Draft GSR 227(E)_To include colour of disinfectants in rule 127 of Drugs Rules 1945
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →2022.03.29_Draft GSR 228(E)_To amend Fourth Schedule wrt TSE or BSE certificate under MDR
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →2022.02.24_Final GSR 158_Inclusion of allura red colour in rule 127 of the Drugs Rules 1945
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →2022.02.24_Final GSR 158(E)_Inclusion of allura red colour in rule 127 of the Drugs Rules 1945
Summary: Automatically discovered on the official CDSCO Alerts page. Open and verify the authority document for product, batch, manufacturer, scope and required action.
Outcome / action: Official-source item discovered automatically; legal and factual verification is pending.
Practical impact: Review the linked authority record before publication or compliance action.
Open source record →